Monitoring Parameters for Quetiapine Treatment
Baseline and Ongoing Monitoring
- The American Psychiatric Association recommends obtaining complete medical and psychiatric history, measuring body mass index (BMI) and waist circumference, checking blood pressure, obtaining fasting blood glucose or HbA1c, ordering fasting lipid panel, checking liver function tests, measuring prolactin levels, obtaining complete blood count, checking renal function, and performing electrocardiogram (ECG) before starting quetiapine treatment 1, 2
- The American Academy of Child and Adolescent Psychiatry suggests monitoring BMI monthly for the first 3 months, then quarterly, and checking blood pressure, fasting glucose, and lipids after 3 months and then yearly 3
- Annual monitoring of liver function, HbA1c, renal function, and vitamin B12 is recommended by the American Psychiatric Association 1, 2
Special Monitoring Considerations
- The American Heart Association recommends monitoring for QTc prolongation, especially in patients with cardiac risk factors 4, 5
- The American Geriatrics Society suggests using lower doses and monitoring more frequently for all parameters in elderly patients 4, 5
- For patients with hepatic impairment, the American Association for the Study of Liver Diseases recommends reducing doses and monitoring liver function more frequently 4, 5
Dose Adjustment or Medication Change
- The American Diabetes Association recommends considering dose adjustment or medication change if patient develops significant metabolic abnormalities (diabetes, severe dyslipidemia) 1, 2
- The American Heart Association suggests considering dose adjustment or medication change if QTc prolongation becomes significant 4, 5